Cargando…

Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy

SIMPLE SUMMARY: Application of drug delivery systems (DDS) in oncology may increase the effectiveness of cancer treatment and reduce the associated adverse side effects. Although various biomaterials can be considered for the development of DDS, the materials of natural origin offer great biocompati...

Descripción completa

Detalles Bibliográficos
Autores principales: Florczak, Anna, Deptuch, Tomasz, Kucharczyk, Kamil, Dams-Kozlowska, Hanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582423/
https://www.ncbi.nlm.nih.gov/pubmed/34771557
http://dx.doi.org/10.3390/cancers13215389
_version_ 1784596982440919040
author Florczak, Anna
Deptuch, Tomasz
Kucharczyk, Kamil
Dams-Kozlowska, Hanna
author_facet Florczak, Anna
Deptuch, Tomasz
Kucharczyk, Kamil
Dams-Kozlowska, Hanna
author_sort Florczak, Anna
collection PubMed
description SIMPLE SUMMARY: Application of drug delivery systems (DDS) in oncology may increase the effectiveness of cancer treatment and reduce the associated adverse side effects. Although various biomaterials can be considered for the development of DDS, the materials of natural origin offer great biocompatibility and degradability. Silk is a natural biomaterial with exceptional properties, and one of them is the possibility to form diverse morphological structures. Scaffolds, films, hydrogels, fibers, foams spheres, capsules, microneedles, among others, can be used for local and systemic drug delivery. In this review, we described the various silk-based DDS for potential application in oncology. However, the unique silk properties combined with the possibility of their further modifications and blending open the gate to numerous potential biomedical applications, not only in the oncology field. ABSTRACT: For years, surgery, radiotherapy, and chemotherapy have been the gold standards to treat cancer, although continuing research has sought a more effective approach. While advances can be seen in the development of anticancer drugs, the tools that can improve their delivery remain a challenge. As anticancer drugs can affect the entire body, the control of their distribution is desirable to prevent systemic toxicity. The application of a suitable drug delivery platform may resolve this problem. Among other materials, silks offer many advantageous properties, including biodegradability, biocompatibility, and the possibility of obtaining a variety of morphological structures. These characteristics allow the exploration of silk for biomedical applications and as a platform for drug delivery. We have reviewed silk structures that can be used for local and systemic drug delivery for use in cancer therapy. After a short description of the most studied silks, we discuss the advantages of using silk for drug delivery. The tables summarize the descriptions of silk structures for the local and systemic transport of anticancer drugs. The most popular techniques for silk particle preparation are presented. Further prospects for using silk as a drug carrier are considered. The application of various silk biomaterials can improve cancer treatment by the controllable delivery of chemotherapeutics, immunotherapeutics, photosensitizers, hormones, nucleotherapeutics, targeted therapeutics (e.g., kinase inhibitors), and inorganic nanoparticles, among others.
format Online
Article
Text
id pubmed-8582423
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85824232021-11-12 Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy Florczak, Anna Deptuch, Tomasz Kucharczyk, Kamil Dams-Kozlowska, Hanna Cancers (Basel) Review SIMPLE SUMMARY: Application of drug delivery systems (DDS) in oncology may increase the effectiveness of cancer treatment and reduce the associated adverse side effects. Although various biomaterials can be considered for the development of DDS, the materials of natural origin offer great biocompatibility and degradability. Silk is a natural biomaterial with exceptional properties, and one of them is the possibility to form diverse morphological structures. Scaffolds, films, hydrogels, fibers, foams spheres, capsules, microneedles, among others, can be used for local and systemic drug delivery. In this review, we described the various silk-based DDS for potential application in oncology. However, the unique silk properties combined with the possibility of their further modifications and blending open the gate to numerous potential biomedical applications, not only in the oncology field. ABSTRACT: For years, surgery, radiotherapy, and chemotherapy have been the gold standards to treat cancer, although continuing research has sought a more effective approach. While advances can be seen in the development of anticancer drugs, the tools that can improve their delivery remain a challenge. As anticancer drugs can affect the entire body, the control of their distribution is desirable to prevent systemic toxicity. The application of a suitable drug delivery platform may resolve this problem. Among other materials, silks offer many advantageous properties, including biodegradability, biocompatibility, and the possibility of obtaining a variety of morphological structures. These characteristics allow the exploration of silk for biomedical applications and as a platform for drug delivery. We have reviewed silk structures that can be used for local and systemic drug delivery for use in cancer therapy. After a short description of the most studied silks, we discuss the advantages of using silk for drug delivery. The tables summarize the descriptions of silk structures for the local and systemic transport of anticancer drugs. The most popular techniques for silk particle preparation are presented. Further prospects for using silk as a drug carrier are considered. The application of various silk biomaterials can improve cancer treatment by the controllable delivery of chemotherapeutics, immunotherapeutics, photosensitizers, hormones, nucleotherapeutics, targeted therapeutics (e.g., kinase inhibitors), and inorganic nanoparticles, among others. MDPI 2021-10-27 /pmc/articles/PMC8582423/ /pubmed/34771557 http://dx.doi.org/10.3390/cancers13215389 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Florczak, Anna
Deptuch, Tomasz
Kucharczyk, Kamil
Dams-Kozlowska, Hanna
Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy
title Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy
title_full Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy
title_fullStr Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy
title_full_unstemmed Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy
title_short Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy
title_sort systemic and local silk-based drug delivery systems for cancer therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582423/
https://www.ncbi.nlm.nih.gov/pubmed/34771557
http://dx.doi.org/10.3390/cancers13215389
work_keys_str_mv AT florczakanna systemicandlocalsilkbaseddrugdeliverysystemsforcancertherapy
AT deptuchtomasz systemicandlocalsilkbaseddrugdeliverysystemsforcancertherapy
AT kucharczykkamil systemicandlocalsilkbaseddrugdeliverysystemsforcancertherapy
AT damskozlowskahanna systemicandlocalsilkbaseddrugdeliverysystemsforcancertherapy